HealthCor Management’s Aerie Pharmaceuticals AERI Stock Holding History

HealthCor Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-302,290	Closed	-$7.31M	–	65
2019 Q4	$7.31M	Buy	+302,290	New	+$6.26M	0.26%	50
2018 Q4	–	Sell	-1,032,127	Closed	-$63.5M	–	49
2018 Q3	$63.5M	Sell	1,032,127 -282,163	-21%	-$18.1M	2.11%	22
2018 Q2	$88.8M	Buy	1,314,290 +114,290	+10%	+$6.39M	2.82%	12
2018 Q1	$65.1M	Buy	+1,200,000	New	+$67.1M	2.21%	14
2015 Q2	–	Sell	-350,000	Closed	-$11M	–	79
2015 Q1	$11M	Buy	+350,000	New	+$10.1M	0.52%	43
2014 Q4	–	Sell	-75,000	Closed	-$1.55M	–	62
2014 Q3	$1.55M	Buy	+75,000	New	+$1.48M	0.08%	48

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

HealthCor Management's AERI Position: Q1 2020 in Review

HealthCor Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 302,290 shares — an estimated $7.31M sold.

HealthCor Management first reported a position in AERI in Q3 2014 and held it in 6 quarters. The position peaked at $88.8M in Q2 2018. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

HealthCor Management reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
HealthCor Management sold 302,290 Aerie Pharmaceuticals shares in Q1 2020, an estimated $7.31M.
HealthCor Management first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 6 quarters.
HealthCor Management's Aerie Pharmaceuticals position peaked at $88.8M in Q2 2018.
155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on HealthCor Management's 13F filing for Q1 2020, filed 15 May 2020.